Altchek's Diagnosis and Management of Ovarian Disorders: Ultrasound, MRI, CT, and PET imaging of ovarian cancer

Ping Gu, Ling-Ling Pan, Shu-Qi Wu, Li Sun, Gang Huang, CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. European Journal of Radiology. ,vol. 71, pp. 164- 174 ,(2009) , 10.1016/J.EJRAD.2008.02.019

R.C. Bast, F.-J. Xu, Y.-H. Yu, S. Barnhill, Z. Zhang, G.B. Mills, CA 125: the past and the future. International Journal of Biological Markers. ,vol. 13, pp. 179- 187 ,(1998) , 10.1177/172460089801300402

Linda W. Wiens, Jeffrey L. Schwartz, John R. Grierson, Janet S. Rasey, Pamella D. Kolb, Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells The Journal of Nuclear Medicine. ,vol. 43, pp. 1210- 1217 ,(2002)

Paula J. Woodward, Keyanoosh Hosseinzadeh, Jeff S. Saenger, From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics. ,vol. 24, pp. 225- 246 ,(2004) , 10.1148/RG.241035178

Azahara Palomar, Cristina Nanni, Paolo Castellucci, Valentina Ambrosini, Gian Carlo Montini, Vincenzo Allegri, Cinzia Pettinato, Adil Al-Nahhas, Angel Soriano, Gaia Grassetto, Domenico Rubello, Stefano Fanti, Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels. Molecular Imaging and Biology. ,vol. 14, pp. 123- 129 ,(2012) , 10.1007/S11307-010-0468-9

M. P.S. Dunphy, J. S. Lewis, Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET The Journal of Nuclear Medicine. ,vol. 50, ,(2009) , 10.2967/JNUMED.108.057281

Angiolo Gadducci, Stefania Cosio, Surveillance of patients after initial treatment of ovarian cancer. Critical Reviews in Oncology Hematology. ,vol. 71, pp. 43- 52 ,(2009) , 10.1016/J.CRITREVONC.2008.12.008

Karen Kinkel, Ying Lu, Amir Mehdizade, Marie-Françoise Pelte, Hedvig Hricak, Indeterminate ovarian mass at US: incremental value of second imaging test for characterization--meta-analysis and Bayesian analysis. Radiology. ,vol. 236, pp. 85- 94 ,(2005) , 10.1148/RADIOL.2361041618

Michael Soussan, Myriam Wartski, Pascal Cherel, Emmanuelle Fourme, Alain Goupil, Elise Le Stanc, Nasrine Callet, Jérôme Alexandre, Alain-Paul Pecking, Jean-Louis Alberini, Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence. Gynecologic Oncology. ,vol. 108, pp. 160- 165 ,(2008) , 10.1016/J.YGYNO.2007.07.082

M.J. Fulham, J. Carter, A. Baldey, R.J. Hicks, J.E. Ramshaw, M. Gibson, The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project. Gynecologic Oncology. ,vol. 112, pp. 462- 468 ,(2009) , 10.1016/J.YGYNO.2008.08.027